Experts now better understand the causes of different types of chronic pain. Here's what to know about the treatments that ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to benefit patients after surgery and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...

Peripheral neuropathy affects millions, often leaving people feeling frustrated, dismissed, and stuck with symptoms like ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into mult | ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Nerve care is frequently neglected until symptoms become disruptive. However, proactive steps may help support nerve health: ...

Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, ...

The experimental drug is similar to the Boston-based company’s recently approved pill Journavx but could potentially be given ...

“At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including ...

New York City, NY, Aug. 02, 2025 (GLOBE NEWSWIRE) -- ...

Audizen Drops’ official launch introduces a thoughtfully crafted supplement for sciatic nerve discomfort and neuropathy. By ...

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...